EP4458806A4 - LIPID AND COMPOSITION FOR ADMINISTRATION - Google Patents

LIPID AND COMPOSITION FOR ADMINISTRATION

Info

Publication number
EP4458806A4
EP4458806A4 EP22914988.5A EP22914988A EP4458806A4 EP 4458806 A4 EP4458806 A4 EP 4458806A4 EP 22914988 A EP22914988 A EP 22914988A EP 4458806 A4 EP4458806 A4 EP 4458806A4
Authority
EP
European Patent Office
Prior art keywords
lipid
administration
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22914988.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4458806A1 (en
Inventor
Lingjian ZHU
Jianyu SHI
Chongyi LIU
Jun Jiang
Jian Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hengrui Pharmaceutical Co Ltd
Shanghai Shengdi Pharmaceutical Co Ltd
Shanghai Senhui Medicine Co Ltd
Original Assignee
Jiangsu Hengrui Pharmaceutical Co Ltd
Shanghai Shengdi Pharmaceutical Co Ltd
Shanghai Senhui Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Pharmaceutical Co Ltd, Shanghai Shengdi Pharmaceutical Co Ltd, Shanghai Senhui Medicine Co Ltd filed Critical Jiangsu Hengrui Pharmaceutical Co Ltd
Publication of EP4458806A1 publication Critical patent/EP4458806A1/en
Publication of EP4458806A4 publication Critical patent/EP4458806A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP22914988.5A 2021-12-29 2022-12-29 LIPID AND COMPOSITION FOR ADMINISTRATION Pending EP4458806A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111638123 2021-12-29
CN202210651178 2022-06-09
PCT/CN2022/143074 WO2023125738A1 (zh) 2021-12-29 2022-12-29 用于递送的脂质和组合物

Publications (2)

Publication Number Publication Date
EP4458806A1 EP4458806A1 (en) 2024-11-06
EP4458806A4 true EP4458806A4 (en) 2025-04-30

Family

ID=86998079

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22914988.5A Pending EP4458806A4 (en) 2021-12-29 2022-12-29 LIPID AND COMPOSITION FOR ADMINISTRATION

Country Status (10)

Country Link
US (1) US20250064750A1 (cg-RX-API-DMAC7.html)
EP (1) EP4458806A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501967A (cg-RX-API-DMAC7.html)
KR (1) KR20240128984A (cg-RX-API-DMAC7.html)
CN (1) CN120476106A (cg-RX-API-DMAC7.html)
AU (1) AU2022424144A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242974A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024007242A (cg-RX-API-DMAC7.html)
TW (1) TW202330458A (cg-RX-API-DMAC7.html)
WO (1) WO2023125738A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4582409A4 (en) * 2022-09-19 2026-06-03 Suzhou Suncadia Biopharmaceuticals Co Ltd PROCESS FOR PREPARING A 2-HYDROXYETHYL AMINOCAPROATE COMPOUND AND ITS USE
EP4736848A1 (en) 2023-06-28 2026-05-06 Shanghai Regenelead Therapies Co., Ltd. Pharmaceutical composition containing cationic lipid and use thereof
TW202532107A (zh) 2023-11-14 2025-08-16 大陸商上海瑞宏迪醫藥有限公司 一種含核酸構建體的醫藥組成物及其醫藥用途
WO2025103414A1 (zh) 2023-11-14 2025-05-22 上海瑞宏迪医药有限公司 一种脂质纳米粒的制备方法和应用
WO2025124548A1 (zh) 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 一种咪唑类脂质及其应用
AU2024401929A1 (en) 2023-12-13 2026-05-28 Shanghai Regenelead Therapies Co., Ltd. Cationic lipid and use thereof
WO2025124560A1 (zh) 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 用于递送治疗剂的组合物和化合物
CN119019272A (zh) * 2024-08-14 2024-11-26 中国药科大学 可电离脂质、包含其的组合物及其用途
CN119191996A (zh) * 2024-11-28 2024-12-27 浙江省质量科学研究院 一种双羟乙基氨基丙基羟乙基油胺的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
CN108368028B (zh) * 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
WO2020219876A1 (en) 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
CN114763324A (zh) * 2021-01-15 2022-07-19 纳肽得(青岛)生物医药有限公司 一种脂质化合物及脂质体与药物组合物
CN113264842B (zh) * 2021-07-21 2022-03-01 苏州科锐迈德生物医药科技有限公司 一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂
CN114773217B (zh) * 2022-06-20 2022-10-18 深圳市瑞吉生物科技有限公司 用于递送核酸的阳离子脂质化合物和组合物及用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
KR20240128984A (ko) 2024-08-27
TW202330458A (zh) 2023-08-01
US20250064750A1 (en) 2025-02-27
JP2025501967A (ja) 2025-01-24
MX2024007242A (es) 2024-06-26
WO2023125738A1 (zh) 2023-07-06
CA3242974A1 (en) 2023-07-06
CN120476106A (zh) 2025-08-12
EP4458806A1 (en) 2024-11-06
AU2022424144A1 (en) 2024-08-08

Similar Documents

Publication Publication Date Title
EP4277616A4 (en) Transdermal penetrant formulations for administration of medicaments
EP3820885A4 (en) METHODS AND COMPOSITIONS FOR ADMINISTRATION OF DRUGS ACROSS THE BLOOD-BRAIN BARRIER
EP3840730A4 (en) COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND METHOD OF USE AND MANUFACTURING THEREOF
EP4457207A4 (en) LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
EP2099408A4 (en) FLUOROPOLYMER-BASED EMULSIONS FOR THE INTRAVENOUS ADMINISTRATION OF VOLATILE FLUORINATED ANESTHETICS
EP4297784A4 (en) COMPOSITIONS AND METHODS OF THERAPEUTIC ADMINISTRATION
EP4204391A4 (en) LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
MA55033A (fr) Formulation d'anticorps thérapeutique
MX377426B (es) Formulaciones de liberación prolongada de colchicina y métodos de uso de las mismas.
EP3928762A4 (en) DELAYED RELEASE LIPID PREFORMULATION AND PHARMACEUTICAL COMPOSITION FOR DELAYED RELEASE INJECTION IN THE FORM OF A LIPID SOLUTION THEREOF
IL313865A (en) Lipid-based formulations for administration of rna
EP4126035A4 (en) Compositions and methods for targeting coronavirus using lipid vesicles including exosomes
EP4281081A4 (en) ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF
EP4337244A4 (en) Pharmaceutical compositions of polypeptide conjugates and methods of using them
EP4054714A4 (en) METHODS AND COMPOSITIONS FOR SELECTIVE INTRACELLULAR DELIVERY OF CD38 INHIBITORS
EP4321152A4 (en) Sustained-release lipid preconcentrate
EP4171611A4 (en) Interleukin-22 fusion proteins, and their pharmaceutical compositions and therapeutic applications
IL307884A (en) Antibody drug conjugates using mates technology for delivering cytotoxic agents
EP2129218A4 (en) COMPOUNDS WITH A CYCLIC PART AND COMPOSITIONS FOR ACTIVE COMPOSITION
EP4337218A4 (en) SELF-PRESERVING COMPOSITIONS AND MULTI-PURPOSE DISPENSER FOR THE DELIVERY OF ALPHA-1062
EP4013401A4 (en) ARTICLES AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS
EP4213881A4 (en) HERV-K ANTIBODY THERAPEUTICS
EP4301336C0 (en) Medical composition for inhalation
EP4259713A4 (en) FORMULATIONS FOR THE DELIVERY OF BIOACTIVE AGENTS
EP4308708A4 (en) OCULAR ADMINISTRATION OF THERAPEUTIC AGENTS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240716

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20250328

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20250324BHEP

Ipc: A61P 31/00 20060101ALI20250324BHEP

Ipc: A61P 29/00 20060101ALI20250324BHEP

Ipc: A61P 25/28 20060101ALI20250324BHEP

Ipc: A61P 37/00 20060101ALI20250324BHEP

Ipc: A61K 31/7105 20060101ALI20250324BHEP

Ipc: A61K 9/00 20060101ALI20250324BHEP

Ipc: A61K 9/127 20060101ALI20250324BHEP

Ipc: A61K 47/18 20170101ALI20250324BHEP

Ipc: A61K 31/7088 20060101ALI20250324BHEP

Ipc: C07C 217/08 20060101ALI20250324BHEP

Ipc: C07C 229/16 20060101ALI20250324BHEP

Ipc: C07C 229/12 20060101AFI20250324BHEP